ClinicalTrials.Veeva

Menu

Early Detection of HCV in Injection Drug Users (EDVIP)

I

Institute of Health Information and Statistics of the Czech Republic

Status

Enrolling

Conditions

Hepatitis C Virus Infection

Treatments

Diagnostic Test: Hepatitis C RNA test and genotype test
Diagnostic Test: Hepatitis C antibody (anti-HCV) test

Study type

Observational

Funder types

Other

Identifiers

NCT06431945
UZIS 2023/1

Details and patient eligibility

About

The project is a national, prospective, multicenter, non-interventional pilot project of screening HCV in PWID in the Czech Republic.

The main goal of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of Hepatitis C and setting up and testing new methods and implementation into the system of social health care.

Full description

The project is a national, prospective, multicenter, non-interventional pilot project of screening HCV in PWID in 18 clinical centers in the Czech Republic.

The main goal of the project is the elimination of further transmission of hepatitis C virus and to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of Hepatitis C and setting up and testing new methods and implementation into the system of social health care.

The project will include testing the procedure on a sample of approx. 3,000 PWID which can help to identify weak points in the continuum of care. A methodology for the continuous care of the target group in the early diagnostic and therapeutic stages will be created. Proposal for a system change towards streamlining the screening process.

The project is supported by the European Social Fund (Operational Program Employment plus) and the state budget of the Czech Republic and is registered by the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22_005/0000281.

Enrollment

3,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18+
  • an active injecting drug user or have used injecting drugs at any time in the past

Exclusion criteria

  • not agreeing to participate in the project

Trial design

3,000 participants in 1 patient group

People who inject drugs
Treatment:
Diagnostic Test: Hepatitis C antibody (anti-HCV) test
Diagnostic Test: Hepatitis C RNA test and genotype test

Trial contacts and locations

18

Loading...

Central trial contact

Nikola Stourac; Lucie Mandelova, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems